Log in to your Inderes Free account to see all free content on this page.
Linc
68.00 SEK
+4.13 %
Less than 1K followers
LINC
NASDAQ Stockholm
Investment
Financials
Overview
Financials & Estimates
Ownership
Investor consensus
+4.13 %
-5.95 %
-9.93 %
-6.34 %
-21.30 %
-10.64 %
+20.35 %
-
-20.00 %
Linc is a company that invests in product-oriented companies within the Nordic Life Science industry. The company invests in and develops primarily small and medium-sized life science companies within Medical Technology and Pharmaceuticals. The investments are made in both private and public companies and in research and operating companies. Linc was founded in 1991 and is headquartered in Stockholm.
Read moreMarket cap
3.94B SEK
Turnover
9.86M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
22.1.
2026
Annual report '25
23.4.
2026
Interim report Q1'26
16.7.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Offering price for Linc’s initial public offering set at SEK 67 per share – trading on Nasdaq Stockholm commences tomorrow
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio